Nuo Therapeutics, Inc. (AURX)
OTCMKTS · Delayed Price · Currency is USD
2.260
0.00 (0.00%)
At close: Dec 5, 2025

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2018 FY 2017 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '18 Dec '17 2019
Innovative Cell-based Technologies
1.37M
Log In
Log In
Log In
Log In
Upgrade
Innovative Cell-based Technologies Growth
124.34%
Log In
Log In
Log In
Log In
Upgrade
License Fees
-
Log In
Log In
Log In
Log In
Upgrade
Product
-
Log In
Log In
Log In
Log In
Upgrade
Royalties
-
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2018 FY 2017 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '18 Dec '17 2019
United States
1.37M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
124.34%
Log In
Log In
Log In
Log In
Upgrade
International
-
Log In
Log In
Log In
Log In
Upgrade
International Growth
-
Log In
Log In
Log In
Log In
Upgrade